Equasens S. A. (PA:EQS) — Market Cap & Net Worth
Market Cap & Net Worth: Equasens S. A. (EQS)
Equasens S. A. (PA:EQS) has a market capitalization of $549.40 Million (€469.93 Million) as of August 5, 2026. Listed on the PA stock exchange, this France-based company holds position #11616 globally and #183 in its home market, demonstrating a -6.74% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Equasens S. A.'s stock price €31.80 by its total outstanding shares 15031400 (15.03 Million). See Equasens S. A. capex to cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
Equasens S. A. Market Cap History: 2015 to 2026
Equasens S. A.'s market capitalization history from 2015 to 2026. Data shows growth from $325.65 Million to $558.83 Million (3.61% CAGR).
Equasens S. A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Equasens S. A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.59x
Equasens S. A.'s market cap is 3.59 times its annual revenue
Latest Price to Earnings (P/E) Ratio
21.48x
Equasens S. A.'s market cap is 21.48 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $325.65 Million | $113.48 Million | $18.79 Million | 2.87x | 17.33x |
| 2016 | $547.03 Million | $128.38 Million | $20.57 Million | 4.26x | 26.60x |
| 2017 | $699.21 Million | $129.67 Million | $23.14 Million | 5.39x | 30.22x |
| 2018 | $823.47 Million | $148.48 Million | $25.43 Million | 5.55x | 32.38x |
| 2019 | $991.01 Million | $158.57 Million | $28.40 Million | 6.25x | 34.89x |
| 2020 | $1.84 Billion | $171.75 Million | $30.71 Million | 10.73x | 60.01x |
| 2021 | $1.57 Billion | $193.07 Million | $39.12 Million | 8.14x | 40.17x |
| 2022 | $1.27 Billion | $214.07 Million | $46.38 Million | 5.91x | 27.29x |
| 2023 | $1.05 Billion | $219.79 Million | $47.05 Million | 4.77x | 22.30x |
| 2024 | $777.62 Million | $216.80 Million | $36.20 Million | 3.59x | 21.48x |
Competitor Companies of EQS by Market Capitalization
Companies near Equasens S. A. in the global market cap rankings as of August 5, 2026.
Key companies related to Equasens S. A. by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #982 globally with a market cap of $27.24 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1913 globally with a market cap of $12.17 Billion USD ( AU$17.21 Billion AUD).
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2124 globally with a market cap of $10.63 Billion USD.
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2588 globally with a market cap of $8.00 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #982 | Veeva Systems Inc Class A | NYSE:VEEV | $27.24 Billion | $206.25 |
| #1913 | Pro Medicus Ltd | AU:PME | $12.17 Billion | AU$164.69 |
| #2124 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $60.47 |
| #2588 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $8.00 Billion | $46.05 |
Equasens S. A. Historical Marketcap From 2015 to 2026
Between 2015 and today, Equasens S. A.'s market cap moved from $325.65 Million to $ 558.83 Million, with a yearly change of 3.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €558.83 Million | -29.33% |
| 2025 | €790.80 Million | +1.69% |
| 2024 | €777.62 Million | -25.90% |
| 2023 | €1.05 Billion | -17.08% |
| 2022 | €1.27 Billion | -19.46% |
| 2021 | €1.57 Billion | -14.75% |
| 2020 | €1.84 Billion | +85.97% |
| 2019 | €991.01 Million | +20.35% |
| 2018 | €823.47 Million | +17.77% |
| 2017 | €699.21 Million | +27.82% |
| 2016 | €547.03 Million | +67.98% |
| 2015 | €325.65 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of Equasens S. A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $549.40 Million USD |
| MoneyControl | $549.40 Million USD |
| MarketWatch | $549.40 Million USD |
| marketcap.company | $549.40 Million USD |
| Reuters | $549.40 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Equasens S. A.
Equasens Société anonyme provides healthcare IT solutions in Europe. The company publishes software and connected solutions for pharmacies, medical-social establishments, doctors, and medical auxiliaries. It also manufactures connected electronic devices and appliances for healthcare professionals and patients. In addition, the company is financing solutions for rental properties for healthcare p… Read more